An FDA panel has recommended that a DNA test that screens for HPV in women can replace the standard Pap smear as a first-line primary cervical cancer screening test.

New evidence reveals that there may be a benefit to continuing cervical cancer screening beyond age 65 years.

Women whose cervical cancer screening ceased between ages 50 and 64 years were 6 times more likely than women who were screened to have cervical cancer from ages 65 to 83 years.

A simple blood test using plasma thermogram could serve as an effective new indicator for detecting cervical cancer, including assessment of the cancer’s stage.

Researchers have developed a new online risk assessment tool that can accurately estimate an individual’s risk of developing colorectal cancer.

An analysis of data from the National Lung Screening Trial found that more than 18% of all lung cancers detected through low-dose CT screening were indolent.

The USPSTF published its final recommendation on screening for lung cancer on December 31, concluding that all people between the ages of 55 and 80 years who are at high risk for lung cancer should undergo low-dose CT screening.


Subscribe to
Please Wait 20 seconds or click here to close